aDepartment of Pharmaceutical Systems and Policy, West Virginia University, and.
bDepartment of Medical Education, WVU School of Medicine, Morgantown, West Virginia; and.
J Natl Compr Canc Netw. 2019 Feb;17(2):149-158. doi: 10.6004/jnccn.2018.7078.
Healthcare spending for coronary artery disease (CAD)-related services is higher than for other chronic conditions. Diagnosis of incident cancer may impede management of CAD, thereby increasing the risk of CAD-related complications and associated healthcare expenditures. This study examined the relationship between incident cancer and CAD-related expenditures among elderly Medicare beneficiaries. A retrospective longitudinal study was conducted using the SEER-Medicare linked registries and a 5% noncancer random sample of Medicare beneficiaries. Elderly fee-for-service Medicare beneficiaries with preexisting CAD and with incident breast, colorectal, or prostate cancer (N=12,095) or no cancer (N=34,237) were included. CAD-related healthcare expenditures comprised Medicare payments for inpatient, home healthcare, and outpatient services. Expenditures were measured every 120 days during the 1-year preindex and 1-year postindex periods. Adjusted relationship between incident cancer and expenditures was analyzed using the generalized linear mixed models. Overall, CAD-related mean healthcare expenditures in the preindex period accounted for approximately 32.6% to 39.5% of total expenditures among women and 41.5% to 46.8% among men. All incident cancer groups had significantly higher CAD-related expenditures compared with noncancer groups (<.0001). Men and women with colorectal cancer (CRC) had 166% and 153% higher expenditures, respectively, compared with their noncancer counterparts. Furthermore, men and women with CRC had 57% and 55% higher expenditures compared with those with prostate or breast cancer, respectively. CAD-related expenditures were higher for elderly Medicare beneficiaries with incident cancer, specifically for those with CRC. This warrants the need for effective programs and policies to reduce CAD-related expenditures. Close monitoring of patients with a cancer diagnosis and preexisting CAD may prevent CAD-related events and expenditures.
冠心病(CAD)相关服务的医疗保健支出高于其他慢性疾病。癌症的诊断可能会妨碍 CAD 的管理,从而增加 CAD 相关并发症的风险和相关的医疗保健支出。本研究调查了老年医疗保险受益人群中癌症发病与 CAD 相关支出之间的关系。
本研究使用 SEER-Medicare 关联登记处和医疗保险非癌症随机样本(占比 5%),开展了一项回顾性纵向研究。研究纳入了患有既往 CAD 且患有新发乳腺癌、结直肠癌或前列腺癌(N=12095)或无癌症(N=34237)的老年医疗保险按服务收费受益人群。CAD 相关医疗保健支出包括医疗保险对住院、家庭保健和门诊服务的支付。在索引前 1 年和索引后 1 年的每 120 天测量支出。使用广义线性混合模型分析癌症发病与支出之间的调整关系。
总体而言,在索引前期间,女性 CAD 相关医疗保健支出占总支出的 32.6%至 39.5%,男性占 41.5%至 46.8%。所有癌症发病组的 CAD 相关支出均显著高于非癌症组(<0.0001)。与非癌症组相比,男性和女性结直肠癌患者的 CAD 相关支出分别增加了 166%和 153%。此外,与患有前列腺癌或乳腺癌的患者相比,患有结直肠癌的男性和女性的 CAD 相关支出分别增加了 57%和 55%。
患有癌症的老年医疗保险受益人群的 CAD 相关支出较高,尤其是患有结直肠癌的人群。这就需要制定有效的计划和政策来降低 CAD 相关支出。密切监测患有癌症诊断和既往 CAD 的患者可能会预防 CAD 相关事件和支出。